Project Grant R21AI193830
Award Date
7/1/25
Completion Date
6/30/27
Dollars Obligated
$518K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
New York, USA
Similar Awards
This federal Project Grant award of $237,165, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to elucidate the molecular mechanisms of internal ribosomal entry site (IRES)-mediated translation initiation in picornaviruses. The goal is to apply an integrated biochemical and structural approach to understand how ribosomes gain access to the sequestered initiation codons in type...
This Project Grant award of $696,544, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under CFDA 93.855 Allergy and Infectious Diseases Research, supports research to investigate the contractile attachment mechanisms of the ventral disc in the parasite Giardia lamblia. The research aims to leverage new CRISPR-based genetic tools and live imaging approaches to evaluate how specific disc structural elements generate the forces underlying Giardia's attachment to the...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $218,767.00 to the University of Washington to conduct a single-cell transcriptional atlas study of Giardia encystation. The research aims to build an atlas of gene expression during the Giardia cell cycle (Aim 1) and differentiation into cyst forms (Aim 2). This work will deepen the understanding of the encystation...
This Project Grant award, valued at $792,687.00 and issued by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to define the structural features of sialoglycans necessary for influenza A virus (IAV) infection and adaptation across various host species. The key activities under this award include: 1) using CRISPR/Cas9 techniques to truncate different types of sialoglycans in human lung...
This $477,226 federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to discover novel antiviral systems in microbial eukaryotes. The research will focus on understanding how the amoeba genus Acanthamoeba defends against giant viruses called Megavirales, and then expand that knowledge to other microbial eukaryotes. The project will leverage cutting-edge AI techniques and...
This $147,656 federal Project Grant award, funded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to understand the role of transmembrane proteins in the cell division process of the malaria parasite Plasmodium falciparum. The award, effective January 22, 2025 through October 31, 2027, will enable the integration of biochemical and super-resolution microscopy approaches to decipher...
This federal Project Grant award, identified as R01AI189569, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award totaling $531,245.00 will fund research at Yale University focused on the structural and functional characterization of the sorting platform, a key component of the type III secretion system (T3SS) in Salmonella bacteria. Through a multidisciplinary approach involving...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the Icahn School of Medicine at Mount Sinai. The $245,895 grant, awarded on November 14, 2024, will support research to systematically investigate the role of ubiquitination events in promoting flavivirus infection using CRISPR-Cas9 base editing approaches. The project aims to discover novel pathways that facilitate flavivirus...
This $502,043 five-year Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), aims to bridge the knowledge gap on how metal ions affect the function of enzymes at the interface of host-pathogen interactions, immune response, and dNTP homeostasis. The key products and services to be delivered under this award include: Dissecting the metal-dependent activities of viral proteases from...
This Project Grant award, totaling $891,678.00, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research (CFDA 93.855) program. The award will fund a project at the Scripps Research Institute in La Jolla, CA focused on using chemoproteomic and functional analysis methods to identify microbiota bile acid-protein targets and characterize their mechanisms of action on host immunity. The goal is to better understand how...